Abstract
1. In rat papillary muscle, stimulation of alpha 1-adrenoceptors results in a biphasic inotropic response: a transient negative inotropic phase and a subsequent sustained positive inotropic phase. This study was designed to determine whether the positive and negative inotropic effects in this tissue are mediated by different alpha 1-adrenoceptor subtypes. 2. After treatment with the tumor-promoting compound, phorbol 12, 13-dibutyrate, phenylephrine (in the presence of propranolol) produced only a positive inotropic effect. The selective alpha 1A-adrenoceptor antagonist, WB4101, significantly inhibited the positive inotropic effect. In contrast, inactivation of alpha 1B-adrenoceptors with chloroethylclonidine (CEC) did not alter the positive effect. 3. In the presence of the Ca2+ channel antagonist, nifedipine, phenylephrine induced only a sustained negative inotropic effect. The negative inotropic effect was significantly attenuated by WB4101, but was not affected by CEC. 4. We conclude that both the positive and negative inotropic responses of rat papillary muscle to phenylephrine are mediated exclusively by the WB4101-sensitive but CEC-resistant alpha 1-adrenoceptor subtype. The alpha 1-adrenoceptor subtype with such a proper...Continue Reading
References
Apr 1, 1978·Acta Pharmacologica Et Toxicologica·J B OsnesI Oye
Sep 1, 1992·Circulation Research·D Fedida, R A Bouchard
May 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·M EndohI Norota
Dec 1, 1992·European Journal of Pharmacology·D A Schwinn, J W Lomasney
Jun 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·M TakanashiM Endoh
Nov 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·R ErtlJ Vereecke
May 1, 1991·Circulation Research·M EndohJ Inui
Apr 1, 1990·Naunyn-Schmiedeberg's Archives of Pharmacology·M C MichelG Gross
Feb 1, 1990·Pflügers Archiv : European journal of physiology·N TohseM Kanno
Feb 1, 1988·Circulation Research·M Endoh, J R Blinks
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S CotecchiaB K Kobilka
Jan 1, 1987·General Pharmacology·N TohseM Kanno
Jul 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·M C MichelD A Schwinn
Nov 1, 1994·Journal of Cardiovascular Pharmacology·G S Yu, C Han
Jul 1, 1995·British Journal of Pharmacology·B A KennyA M Naylor
Feb 1, 1995·British Journal of Pharmacology·H TanakaK Shigenobu
Aug 24, 1993·European Journal of Pharmacology·H NoguchiI Muramatsu
Feb 1, 1994·British Journal of Pharmacology·M C MichelG Gross
Feb 1, 1994·British Journal of Pharmacology·M C MichelG Gross
Apr 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·U JahnelH Nawrath
Feb 22, 1996·European Journal of Pharmacology·S A BucknerA A Hancock
Citations
Jun 28, 2001·European Journal of Pharmacology·H OtaniC Inagaki
Jun 29, 1999·Journal of Autonomic Pharmacology·K J BroadleyA G Roach
Oct 24, 2006·Acta Physiologica·K KamataK Shigenobu
Nov 23, 2005·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·J S KimJ-S Kim
Aug 16, 2001·Critical Care Medicine·S HoltzerP Escourrou
Apr 13, 2021·Biochemical Pharmacology·Sarah K WalshCherry L Wainwright
Jul 24, 2021·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Alexey S AverinOlga V Nakipova
Aug 2, 2011·Journal of Molecular and Cellular Cardiology·E P ScholzE Zitron